It is a oral insulin play - we need progress on enrollment of both trials. The interim analysis at 26 weeks - it needs 100% enrollment done - we have not got any update on that - the topline results will come approx 6-8 weeks after last visit by last patient - so 34 weeks (8.5 months) after last patient enrollment which they have not confirmed. To get the results before 2022 end, they need to finish the last patient enrollment by mid-April else the results will go into 2023.
Overall progress is slow in oral insulin area.
The NASH trial enrollment is done - that is 12 weeks trial and sample size is small - so we can see top line results by Jul end. If P2 results are good we can see good SP jump
News 
Market Data 
Discover 
